New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
06:03 EDTAQXPAquinox reports Q1 net loss of $4.2M, compared to a loss of $1M a year ago
The increase in net loss was primarily due to the advancement of AQX-1125 into two Phase 2 clinical trials and public company-related expenses.
News For AQXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2015
09:18 EDTAQXPAquinox abstract from Leadership clinial trial accepted at 2015 ESSIC
Aquinox Pharmaceuticals announced that an abstract from the LEADERSHIP Phase 2 clinical trial with AQX-1125 in bladder pain syndrome/interstitial cystitis has been accepted for oral presentation at the 2015 ESSIC Annual Meeting to be held in Rome, Italy from Thursday, September 17th to Saturday, September 19th. Aquinox will present in the first Abstract Session scheduled for September 18th at 12:00 PM local time. The abstract is under embargo until after the session; accordingly, no details of the abstract may be shared in advance. The abstract is entitled, "Safety and Efficacy of AQX-1125 in Interstitial Cystitis/Bladder Pain Syndrome - Results of the Phase 2 LEADERSHIP Trial."
August 24, 2015
16:13 EDTAQXPRA Capital Management reports 9.6% passive stake in Aquinox
Subscribe for More Information
August 17, 2015
09:26 EDTAQXPOn The Fly: Pre-market Movers
HIGHER: AVEO (AVEO), up 119.7% after announcing licensing agreement with Novartis (NVS)... OHR Pharmaceutical (OHRP), up 24.9% after Soros reports new stake in company in 13F filing... Kite Pharma (KITE), up 4.6% after saying patient death unrelated to KTE-C19... Tesla (TSLA), up 5.5% after price target raised to $465 from $280 at Morgan Stanley... Mobileye (MBLY), up 2.7% after price target raised to $80 from $71 at Morgan Stanley... J.C. Penney (JCP), up 1.5% after being initiated with a Buy at B. Riley and Piper Jaffray raised its price target to $17 from $15. DOWN AFTER EARNINGS: Estee Lauder (EL), down 2.1% after reporting quarterly results and giving guidance for first quarter and fiscal 2016. ALSO LOWER: KKR (KKR), down 3.3% after Samson enters restructuring deal and expects to file for bankruptcy within 30 days... Aquinox (AQXP), down 4.7% after Lloyd Mackenzie, vice president - Technical Operations and Planning, disclosed late Friday the sale of 35,887 shares worth over $670,000 in a sale related to the exercise of options.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use